Venture Life Regulatory News (VLG)

Venture Life Group plc

("Venture Life" or the "Group")

Investor presentation

Venture Life Group (AIM: VLG), the international consumer self-care company focused on developing, manufacturing and commercialising products for the self-care market, is pleased to announce that Jerry Randall, CEO, will be presenting at an investor evening hosted by Turner Pope Investments ("TPI") Ltd.

TPI has been joint broker to Venture Life Group since September 2016. The event will be held on Monday 26 February in the City of London and will commence at 6pm. To Register your interest, please email info@turnerpope.com or call 0203 621 4120.

For further information please contact:

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising self-care products globally. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its Development & Manufacturing business, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.